Aeterna Zentaris (AEZS) Stock Chart & Stock Price History → What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (From Weiss Ratings) (Ad) Free AEZS Stock Alerts C$13.00 -0.28 (-2.11%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Aeterna Zentaris Stock Price Performance5 Day Performance+12.85%1 Month Performance+371.01%3 Month Performance+394.30%6 Month Performance+390.57%Year-To-Date Performance+405.84%1 Year Performance+255.19% Receive AEZS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aeterna Zentaris and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. AEZS Stock Chart for Sunday, June, 2, 2024 AEZS Chart by TradingView Aeterna Zentaris Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024C$13.28C$13.00-2.11%C$13.18C$13.00601 shsC$15.73 million05/30/2024C$13.90C$13.28-4.46%C$14.28C$13.281,320 shsC$16.07 million05/29/2024C$11.52C$13.90+20.66%C$15.13C$11.758,602 shsC$16.82 million05/28/2024C$11.63C$11.52-0.95%C$11.65C$11.45721 shsC$13.94 million05/27/2024C$11.69C$11.63-0.51%C$11.63C$11.63100 shsC$14.07 million05/24/2024C$11.69C$11.69C$11.69C$11.59300 shsC$14.15 million Get the Latest News and Ratings for AEZS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aeterna Zentaris and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024C$11.54C$11.69+1.30%C$11.69C$11.59314 shsC$14.15 million05/22/2024C$11.54C$11.54C$11.55C$11.54272 shsC$13.96 million05/21/2024C$11.57C$11.54-0.26%C$11.55C$11.54272 shsC$13.96 million05/20/2024C$11.57C$11.57C$11.60C$11.571,610 shsC$14 million05/17/2024C$11.55C$11.57+0.17%C$11.60C$11.571,610 shsC$14 million05/16/2024C$11.79C$11.55-2.04%C$11.98C$11.551,360 shsC$13.98 million05/15/2024C$11.60C$11.79+1.64%C$11.93C$11.60929 shsC$14.27 million05/14/2024C$11.06C$11.60+4.88%C$11.60C$11.051,326 shsC$14.04 million05/13/2024C$11.09C$11.06-0.27%C$11.69C$11.062,816 shsC$13.38 million05/10/2024C$10.70C$11.09+3.64%C$11.09C$10.721,544 shsC$53.90 million05/09/2024C$10.76C$10.70-0.56%C$10.98C$10.701,641 shsC$52.00 million05/08/2024C$11.49C$10.76-6.35%C$11.47C$10.762,102 shsC$52.29 million05/07/2024C$10.70C$11.49+7.38%C$11.49C$11.03845 shsC$55.84 million05/06/2024C$10.79C$10.70-0.83%C$10.70C$10.64383 shsC$52.00 million05/03/2024C$2.76C$10.79+290.94%C$10.94C$10.79271 shsC$52.44 million05/02/2024C$2.82C$2.76-2.13%C$2.85C$2.652,142 shsC$13.41 million05/01/2024C$2.60C$2.82+8.46%C$2.97C$2.778,609 shsC$13.71 million04/30/2024C$2.67C$2.60-2.62%C$2.98C$2.6011,231 shsC$12.64 million04/29/2024C$2.65C$2.67+0.75%C$2.67C$2.651,616 shsC$12.98 million04/26/2024C$2.66C$2.65-0.38%C$2.65C$2.65603 shsC$12.88 million04/25/2024C$2.66C$2.66C$2.68C$2.661,205 shsC$12.93 million04/23/2024C$2.66C$2.66C$2.68C$2.661,212 shsC$12.93 million04/22/2024C$2.67C$2.66-0.37%C$2.68C$2.661,212 shsC$12.93 million04/19/2024C$2.67C$2.67C$2.67C$2.67200 shsC$12.98 million04/18/2024C$2.76C$2.67-3.26%C$2.67C$2.67179 shsC$12.98 million04/17/2024C$2.70C$2.76+2.22%C$2.76C$2.76269 shsC$13.41 million04/16/2024C$2.70C$2.70C$2.74C$2.703,000 shsC$13.12 million04/15/2024C$2.79C$2.70-3.23%C$2.72C$2.691,615 shsC$13.12 million04/12/2024C$2.82C$2.79-1.06%C$2.79C$2.79384 shsC$13.56 million04/11/2024C$2.85C$2.82-1.05%C$2.82C$2.82329 shsC$13.71 million04/10/2024C$2.77C$2.85+2.89%C$2.85C$2.85118 shsC$13.85 million04/09/2024C$2.77C$2.77C$2.77C$2.73800 shsC$13.46 million04/08/2024C$2.68C$2.77+3.36%C$2.77C$2.73800 shsC$13.46 million04/05/2024C$2.77C$2.68-3.25%C$2.76C$2.683,531 shsC$13.03 millionTrump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024.04/04/2024C$2.84C$2.77-2.46%C$2.84C$2.773,921 shsC$13.46 million04/03/2024C$2.86C$2.84-0.70%C$2.85C$2.811,326 shsC$13.80 million04/02/2024C$2.91C$2.86-1.72%C$2.90C$2.862,400 shsC$13.90 million04/01/2024C$2.91C$2.91C$2.95C$2.911,424 shsC$14.14 million03/29/2024C$2.91C$2.91C$3.01C$2.802,920 shsC$14.14 million03/28/2024C$2.83C$2.91+2.83%C$3.01C$2.802,920 shsC$14.14 million03/27/2024C$2.77C$2.83+2.17%C$2.83C$2.721,954 shsC$13.75 million03/26/2024C$2.75C$2.77+0.73%C$2.77C$2.70800 shsC$13.46 million03/25/2024C$2.83C$2.75-2.83%C$2.75C$2.75390 shsC$13.37 million03/22/2024C$2.74C$2.83+3.28%C$2.83C$2.781,700 shsC$13.75 million03/21/2024C$2.76C$2.74-0.72%C$2.97C$2.74700 shsC$13.32 million03/20/2024C$2.86C$2.76-3.50%C$2.84C$2.763,038 shsC$13.41 million03/19/2024C$2.85C$2.86+0.35%C$3.06C$2.789,219 shsC$13.90 million03/18/2024C$2.89C$2.85-1.38%C$2.86C$2.85413 shsC$13.85 million03/15/2024C$2.72C$2.89+6.25%C$3.05C$2.817,600 shsC$14.05 million03/14/2024C$2.75C$2.72-1.09%C$2.75C$2.704,160 shsC$13.22 million03/13/2024C$2.72C$2.75+1.10%C$2.75C$2.582,800 shsC$13.37 million03/12/2024C$2.61C$2.72+4.21%C$3.18C$2.577,050 shsC$13.22 million03/11/2024C$2.61C$2.61C$2.61C$2.61103 shsC$12.69 million03/08/2024C$2.46C$2.61+6.10%C$2.61C$2.61105 shsC$12.69 million03/07/2024C$2.58C$2.46-4.65%C$2.63C$2.464,160 shsC$11.96 million03/06/2024C$2.52C$2.58+2.38%C$2.64C$2.581,822 shsC$12.54 million03/05/2024C$2.57C$2.52-1.95%C$2.56C$2.52744 shsC$12.25 million03/04/2024C$2.63C$2.57-2.28%C$2.65C$2.57204 shsC$12.49 million03/01/2024C$2.63C$2.63C$2.63C$2.62410 shsC$12.78 million Related Companies: Helix BioPharma Stock Chart Microbix Biosystems Stock Chart IBEX Technologies Stock Chart BriaCell Therapeutics Stock Chart Devonian Health Group Stock Chart Covalon Technologies Stock Chart Aptose Biosciences Stock Chart Ceapro Stock Chart Kane Biotech Stock Chart Antibe Therapeutics Stock Chart Receive AEZS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aeterna Zentaris and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:AEZS) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBiden replacement revealed?Paradigm PressThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aeterna Zentaris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
